Baseline Eye Exams Urged
CHATTANOOGA, Tenn. (WDEF) – GLP-1 medications, often prescribed for diabetes management and weight loss, are growing in popularity in the U.S., with roughly 12% of adults having used them at some point.
These drugs can provide meaningful improvements in blood sugar control and support weight loss goals.
However, recent reports have highlighted rare but potentially serious eye complications among some users. Allegedly loss of vision has doubled amongst the population of people taking G-L-P-One medication.
This has led the American Optometric Association (AOA) to recommend that patients include an optometrist in their care team before starting GLP-1 therapy.
A comprehensive eye exam before treatment, or within a month or two after starting, establishes a baseline to monitor vision changes over time.
Dr. Jacqueline Brown, president of the AOA, explains, “We want to make people aware that having a comprehensive eye exam with an optometrist within the year prior to starting these medications or within a month or two after starting them is a good idea just to assess risk and make sure there is nothing going on in the eye that you are not paying attention to or that you’re not able to even detect.”
Even patients who have never experienced eye problems should follow annual eye exam recommendations, as vision changes can be subtle and sometimes go unnoticed.
Certain patients, especially those with preexisting eye conditions, diabetes-related complications, or other health concerns, may face higher risks, making early evaluation especially important.
Experts also stress that communication between your healthcare providers is key.
Keeping your optometrist informed about any new medications allows for better monitoring and faster response if changes in vision occur.
Patients are encouraged to report any vision changes immediately and to schedule follow-up exams as advised.
In short, adding an optometrist to your GLP-1 care plan helps protect your eye health while you benefit from these medications.
